Cleveland Clinic and Ascension Ventures contributed to a $15.8m round for Cardionomic, which is developing a neuromodulation system to treat heart failure.
Month: February 2020
Award winners step up to greater roles
It did not take long for my colleague, Liwen-Edison Fu to be proven right in the selection process for last month’s Global Corporate Venturing Rising Stars and Emerging Leaders awards.
Grab takes $856m amidst Gojek merger rumours
Reports suggest Grab, which just raised $856m from strategic partners TIS and Mitsubishi UFJ Financial Group, is in talks to merge with rival Gojek in a $23bn deal.
Karius passes series B test with $165m
The blood test developer took in $165m through a series B round led by SoftBank Vision Fund 2 that came three years after a Tencent-backed series A.
Graphcore grows series D to $350m
The AI platform developer has added $150m to a round that already included BMW, Robert Bosch, Dell, Microsoft and Samsung and is now valued just shy of $2bn.
Behavox spies $100m Vision Fund investment
The Citigroup-backed internal communication monitoring platform received $100m from SoftBank Vision Fund 2 that will fund international growth.
Rupeek scoops up $60m
Gold-based lender Rupeek, which counts Bertelsmann India Investments as a backer, has snagged funding at a valuation of more than $300m.
Intel initiates internal incubator
Emerging Growth and Incubation has selected eight groups of technology developers from its global offices, and candidates could theoretically receive hundreds of millions to fund the ideas.
Vogo scoots to $19m series C
Ola-backed urban mobility service Vogo secured the funding at a reported valuation of just over $76m, with LGT Lightstone leading the round.
Luse lasers in on Ferguson Ventures leadership role
GCV Emerging Leader Blake Luse, previously a director at Ferguson Ventures, has been appointed head of the unit and a senior director at its parent company.
Invetx gets $15m in investment
Manufacturing partner WuXi Biologics participated in a series A round for the startup, which aims to transfer human biopharmaceutical practices to animal drug development.
US should set up a $10bn AI fund
Comment from Ben Lamm, chief executive, Hypergiant
AI hardware innovation: a tale of east and west
Nvidia, Intel and others are piling innovation resources into AI-specialised chip architectures amid heightened risk of competition from Chinese vendors
AI comes to the fore
February 2020 AI supplement editorial by James Mawson, editor in chief, Global Corporate Venturing